Sabra Health Care REIT, Inc. SBRA R2KR3K
Company Overview
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
Why Investors Should Care
Net profit has compounded at 19.5% per year over the last five years.
Revenue has grown at a 10.9% CAGR over the past five years.
Offers a dividend yield of 5.74%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $356.88M (+25.4% YoY); net profit $155.61M.
- Trailing 12 Months Year-on-year growth — revenue +25.3%, earnings +22.8%.
- 5-Year Trend Long-term compounding — revenue CAGR 10.9%, profit CAGR 19.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 10.86% |
| 1 Year: | 25.30% |
Compounded Profit Growth
| 5 Years: | 19.50% |
| 1 Year: | 22.81% |
Stock Price Performance
| 1 Year: | +19.29% |
| 6 Months: | +4.78% |
| 3 Months: | +14.27% |
| 1 Month: | +0.88% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)53.66 · Neutral
P/E of 79.92 is above the sector median of 24.38 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 10.9% over 5 years.
- Profit CAGR of 19.5% over 5 years.
- Attractive dividend yield of 5.74%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 79.9.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Real Estate).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SBRA Sabra Health Care REIT, Inc. R2KR3K | 20.78 | 79.92 | $5.31B | 5.74% | - | 2.39% | 10.86% | 19.50% |
| 2 | WELL Welltower Inc. SPXR3K | 236.17 | 106.38 | $170.18B | 1.44% | 0.54% | 3.84% | 22.26% | 11.10% |
| 3 | PLD Prologis, Inc. SPXR3K | 137.34 | 30.59 | $130.52B | 3.08% | - | 7.75% | 16.83% | 39.42% |
| 4 | EQIX Equinix, Inc. SPXR3K | 1,035.98 | 66.49 | $102.22B | 1.96% | 5.42% | 10.73% | 17.43% | 17.11% |
| 5 | AMT American Tower Corporation SPXR3K | 175.85 | 28.36 | $81.94B | 4.08% | 8.76% | 33.91% | 12.41% | 25.08% |
| 6 | DLR Digital Realty Trust, Inc. SPXR3K | 188.39 | 241.53 | $69.71B | 2.44% | - | 2.91% | 15.18% | 18.41% |
| 7 | SPG Simon Property Group, Inc. SPXR3K | 209.44 | 14.57 | $67.92B | 3.97% | - | 113.59% | 3.14% | 14.02% |
| 8 | O Realty Income Corporation SPXR3K | 61.25 | 44.71 | $57.95B | 5.21% | - | 3.23% | 24.73% | 13.04% |
| 9 | PSA Public Storage SPXR3K | 302.01 | 28.74 | $56.40B | 3.67% | - | 21.93% | 5.67% | 7.85% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2013 | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17.49M | 17.53M | 17.40M | 17.06M | 36.07M | 36.41M | 39.98M | 38.58M | 39.34M | 36.04M | 39.12M | 39.82M | 42.23M | 44.14M | 47.61M | 56.72M | 58.43M | 59.75M | 66.03M | 67.94M | 73.75M | 77.45M | 78.98M | 92.02M | 116.69M | 128.80M |
| Net Income | -662.00K | 11.82M | -7.30M | 14.80M | 17.20M | 19.45M | 16.84M | 18.06M | -15.71M | 37.48M | 25.34M | 18.82M | 20.52M | 15.10M | 62.47M | 200.79M | 35.22M | -77.70M | 83.68M | 23.28M | - | 29.62M | 36.46M | 33.45M | -132.57M | 10.22M | 40.60M | 16.80M | -50.06M | -9.49M | 21.19M | -15.10M | 26.25M | 23.98M | 29.79M | 40.30M | 65.54M | 22.54M | 40.88M | -25.20M |
| Diluted EPS | -0.09 | 0.24 | -0.25 | 0.28 | 0.31 | 0.28 | 0.24 | 0.24 | -0.28 | 0.53 | 0.35 | 0.25 | 0.27 | 0.11 | 0.34 | 1.08 | 0.20 | -0.44 | 0.46 | 0.12 | 0.17 | 0.14 | 0.18 | 0.16 | -0.61 | 0.05 | 0.18 | 0.07 | -0.22 | -0.04 | 0.09 | -0.07 | 0.11 | 0.10 | 0.13 | 0.17 | 0.27 | 0.09 | 0.16 | -0.10 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 84.22M | 103.17M | 134.78M | 183.52M | 238.86M | 260.53M | 26.43M | 70.14M | 128.06M | 156.04M | 155.51M | 186.67M | 236.15M | 284.58M | 356.88M |
| Net Income | 12.84M | 19.51M | 33.72M | 46.95M | 79.41M | 70.28M | 158.38M | 279.08M | 69.00M | 138.42M | -113.26M | -77.61M | 13.76M | 126.71M | 155.61M |
| Diluted EPS | 0.43 | 0.52 | 0.68 | 0.78 | 1.11 | 0.92 | 1.40 | 1.51 | 0.37 | 0.67 | -0.52 | -0.34 | 0.06 | 0.54 | 0.64 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Nov 2010 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 595.92M | 599.56M | 749.65M | 916.88M | 1.17B | 2.06B | 2.47B | 2.27B | 7.03B | 6.67B | 6.07B | 5.99B | 5.97B | 5.75B | 5.39B | 5.30B | 5.49B |
| Total Equity | 177.19M | 177.53M | 326.57M | 305.49M | 460.16M | 941.82M | 1.05B | 1.02B | 3.43B | 3.25B | 3.49B | 3.41B | 3.38B | 3.06B | 2.80B | 2.74B | 2.82B |
| Cash & Equivalents | 67.13M | 42.25M | 42.25M | 17.10M | 4.31M | 61.79M | 7.43M | 25.66M | 518.63M | 50.23M | 39.10M | 59.08M | 112.00M | 49.31M | 41.28M | 60.47M | 71.54M |
| Long Term Debt | - | - | - | 569.82M | 688.08M | 1.09B | 1.40B | 1.21B | 3.39B | 3.23B | 2.40B | 2.37B | 2.39B | 2.51B | 2.41B | 2.42B | 2.53B |
| Total Liabilities | 418.73M | 422.03M | 423.08M | 611.39M | 713.46M | 1.12B | 1.41B | 1.25B | 3.60B | 3.41B | 2.58B | 2.58B | 2.59B | 2.69B | 2.58B | 2.56B | 2.67B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 44.70M | 56.25M | 62.10M | 85.34M | 121.10M | 175.93M | 135.79M | 360.59M | 372.48M | 354.85M | 356.39M | 315.73M | 300.57M | 310.54M | 348.61M |
| Investing Cash Flow | -204.59M | -218.65M | -297.51M | -826.47M | -489.23M | 142.36M | -182.56M | -258.49M | 262.84M | -136.45M | -336.20M | -216.25M | 103.13M | -109.00M | -377.96M |
| Financing Cash Flow | 127.90M | 137.25M | 222.62M | 798.62M | 314.08M | -300.90M | 598.82M | -629.34M | -646.18M | -202.11M | 30.14M | -161.71M | -410.30M | -181.56M | 40.76M |
| Dividends Paid | 31.64M | 48.93M | 58.15M | 81.49M | 109.90M | 119.26M | 182.09M | 325.22M | 335.44M | 278.30M | 262.92M | 277.16M | 277.45M | 280.15M | 289.50M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Margin % | 15.2% | 18.9% | 25.0% | 25.6% | 33.2% | 27.0% | 599.3% | 397.9% | 53.9% | 88.7% | -72.8% | -41.6% | 5.8% | 44.5% | 43.6% |
| ROE % | 3.9% | 6.4% | 7.3% | 5.0% | 7.5% | 6.9% | 4.6% | 8.6% | 2.0% | 4.1% | -3.4% | -2.5% | 0.5% | 4.6% | 5.5% |
| ROCE % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 16.29% | 41.61M | $857.67M |
| 2 | Principal Financial Group, Inc. | 9.67% | 24.71M | $509.19M |
| 3 | Vanguard Portfolio Management LLC | 9.14% | 23.35M | $481.29M |
| 4 | State Street Corporation | 4.82% | 12.31M | $253.62M |
| 5 | Vanguard Capital Management LLC | 4.44% | 11.35M | $233.91M |
| 6 | Geode Capital Management, LLC | 3.10% | 7.91M | $163.01M |
| 7 | CenterSquare Investment Management LLC | 2.28% | 5.81M | $119.84M |
| 8 | Bank of America Corporation | 2.07% | 5.30M | $109.25M |
| 9 | Charles Schwab Investment Management, Inc. | 1.89% | 4.84M | $99.76M |
| 10 | Nuveen, LLC | 1.75% | 4.46M | $92.02M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SBRA
Sabra Health Care REIT (SBRA) Q2 2026 Earnings Call Transcript
Managed senior housing transition drives gains amid record investment pipeline activity.
Sabra Health Care REIT (SBRA) Could Be 5% Below Fair Value Following AFFO And Outlook Reaffirmation
Sabra Health Care REIT (SBRA) is back in focus after its latest quarterly update. The company reported higher normalized AFFO, reaffirmed an improved 2026 outlook, highlighted lower leverage and kept its dividend unchanged. See our latest a…
Sabra Health Care REIT Inc (SBRA) (Q2 2026) Earnings Call Highlights: Strong Senior Housing ...
Sabra Health Care REIT Inc (SBRA) reports robust Q2 2026 results with normalized AFFO per share up 5% year-over-year, significant leverage reduction, and a $1 billion investment pipeline.
Sabra Healthcare (SBRA) Tops Q2 FFO and Revenue Estimates
Sabra (SBRA) delivered FFO and revenue surprises of +2.56% and +3.87%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report
TUSTIN, Calif., July 23, 2026--Sabra Health Care REIT, Inc. ("Sabra" or the "Company") (Nasdaq: SBRA) today released its sixth annual Sustainability Report for fiscal year 2025.
Strength Seen in Sabra (SBRA): Can Its 10.2% Jump Turn into More Strength?
Sabra (SBRA) was a big mover last session on higher-than-average trading volume. The latest trend in FFO estimate revisions might not help the stock continue moving higher in the near term.
SBRA — Frequently Asked Questions
What is the current share price of Sabra Health Care REIT, Inc. (SBRA)?
As of 2026-09-07 16:24 PDT, Sabra Health Care REIT, Inc. (SBRA) trades at $20.78 on NasdaqGS. Its 52-week range is $16.22 to $22.06.
What is the market capitalisation of SBRA?
Sabra Health Care REIT, Inc. (SBRA) has a market capitalisation of $5.31B on NasdaqGS.
What is the P/E ratio of SBRA?
SBRA trades at a trailing price-to-earnings (P/E) ratio of 79.92. The industry average P/E is 24.38. Its price-to-book (P/B) ratio is 1.95.
Does SBRA pay a dividend?
Sabra Health Care REIT, Inc. (SBRA) currently offers a dividend yield of 5.74%.
What is the return on equity (ROE) of SBRA?
SBRA has a return on equity (ROE) of 2.39%.
Is SBRA a good stock to buy?
This page provides a data-driven analysis of Sabra Health Care REIT, Inc. (SBRA), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.